As SARS-CoV-2 continues to spread and cause diseases, emerging variants of the

virus are being identified around the globe.

The persisting challenges of SARS-CoV-2 to the international public health system

have elicited concerns among scientists, drug and vaccine developers and the

general population. Whether current therapeutic antibodies and vaccines against

the circulating and emerging variants can provide enough protection becomes a

primary issue.


ACROBiosystems has been tracking the most up-to-date genomic data of the virus

and going full steam ahead on SARS-CoV-2 variants-related product development.

Now we present a complete solution to support your research and development

on the variants: a collection of recombinant antigens, antibodies, ELISA kits

and magnetic beads is now available now at ACROBiosystems.


Find out more information here


Richiedi un'offerta

Via Umbria 10
20054 Segrate (Milano)

Tel. +39 02-26922300
Fax +39 02-26926058
Fax +39 02-26923535

If you no longer wish to receive these announcements click here